Connection

WOLFGANG WINKELMAYER to Kidney Transplantation

This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Kidney Transplantation.
Connection Strength

11.126
  1. Prospectively Examining Outcomes After Living Kidney Donation: Informing the Altruist. JAMA. 2024 07 23; 332(4):285-286.
    View in: PubMed
    Score: 0.631
  2. The Association of Pre-Kidney Transplant Dialysis Modality with de novo Posttransplant Heart Failure. Cardiorenal Med. 2021; 11(5-6):209-217.
    View in: PubMed
    Score: 0.516
  3. Trends in the Medical Complexity and Outcomes of Medicare-insured Patients Undergoing Kidney Transplant in the Years 1998-2014. Transplantation. 2019 11; 103(11):2413-2422.
    View in: PubMed
    Score: 0.455
  4. De Novo Heart Failure After Kidney Transplantation: Trends in Incidence and Outcomes. Am J Kidney Dis. 2018 08; 72(2):223-233.
    View in: PubMed
    Score: 0.407
  5. Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States. Transplantation. 2017 10; 101(10):2636-2647.
    View in: PubMed
    Score: 0.393
  6. Statin use and hip fractures in U.S. kidney transplant recipients. BMC Nephrol. 2017 May 01; 18(1):145.
    View in: PubMed
    Score: 0.382
  7. Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients. Am J Kidney Dis. 2017 May; 69(5):595-601.
    View in: PubMed
    Score: 0.370
  8. Kidney Transplantation Outcomes across GN Subtypes in the United States. J Am Soc Nephrol. 2017 02; 28(2):632-644.
    View in: PubMed
    Score: 0.362
  9. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA. Nephrol Dial Transplant. 2016 Feb; 31(2):290-8.
    View in: PubMed
    Score: 0.346
  10. Patient characteristics and outcomes by GN subtype in ESRD. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1170-8.
    View in: PubMed
    Score: 0.336
  11. Comparison of longer-term outcomes after kidney transplantation between Hispanic and non-Hispanic whites in the United States. Am J Transplant. 2015 Feb; 15(2):499-507.
    View in: PubMed
    Score: 0.325
  12. Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation. Nephrol Dial Transplant. 2015 Feb; 30(2):321-9.
    View in: PubMed
    Score: 0.321
  13. Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States. Am J Transplant. 2014 Apr; 14(4):943-951.
    View in: PubMed
    Score: 0.306
  14. Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation. Am J Transplant. 2013 Jun; 13(6):1566-75.
    View in: PubMed
    Score: 0.291
  15. Air pollution and coronary risk in kidney transplant recipients. Am J Kidney Dis. 2011 Oct; 58(4):506-7.
    View in: PubMed
    Score: 0.260
  16. Posttransplantation anemia: mechanisms and management. Clin J Am Soc Nephrol. 2011 Jul; 6(7):1794-801.
    View in: PubMed
    Score: 0.255
  17. Pottransplantation anemia: management and rationale. Clin J Am Soc Nephrol. 2008 Mar; 3 Suppl 2:S49-55.
    View in: PubMed
    Score: 0.202
  18. Predialysis nephrologist care and access to kidney transplantation in the United States. Am J Transplant. 2007 Apr; 7(4):872-9.
    View in: PubMed
    Score: 0.190
  19. A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients. Transpl Int. 2007 Jun; 20(6):505-11.
    View in: PubMed
    Score: 0.189
  20. A prospective study of anaemia and long-term outcomes in kidney transplant recipients. Nephrol Dial Transplant. 2006 Dec; 21(12):3559-66.
    View in: PubMed
    Score: 0.184
  21. Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients. Kidney Int. 2005 Dec; 68(6):2857-62.
    View in: PubMed
    Score: 0.173
  22. Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients. Kidney Int. 2005 May; 67(5):1980-5.
    View in: PubMed
    Score: 0.166
  23. Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients. Am J Transplant. 2004 Dec; 4(12):2075-81.
    View in: PubMed
    Score: 0.162
  24. Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. J Am Soc Nephrol. 2005 Jan; 16(1):255-60.
    View in: PubMed
    Score: 0.161
  25. Trends in Kidney Allograft Failure Among First-Time Transplant Recipients in the United States. Am J Kidney Dis. 2025 Mar; 85(3):273-283.e1.
    View in: PubMed
    Score: 0.161
  26. Patterns of co-occurrence of three single nucleotide polymorphisms of the 5,10-methylenetetrahydrofolate reductase gene in kidney transplant recipients. Eur J Clin Invest. 2004 Sep; 34(9):613-8.
    View in: PubMed
    Score: 0.159
  27. C-reactive protein and body mass index independently predict mortality in kidney transplant recipients. Am J Transplant. 2004 Jul; 4(7):1148-54.
    View in: PubMed
    Score: 0.157
  28. Effects of TCN2 776C>G on vitamin B, folate, and total homocysteine levels in kidney transplant patients. Kidney Int. 2004 May; 65(5):1877-81.
    View in: PubMed
    Score: 0.155
  29. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol. 2004 May; 15(5):1347-52.
    View in: PubMed
    Score: 0.155
  30. Methionine synthase reductase MTRR 66A > G has no effect on total homocysteine, folate, and Vitamin B12 concentrations in renal transplant patients. Atherosclerosis. 2004 May; 174(1):43-8.
    View in: PubMed
    Score: 0.155
  31. Patient and graft survival in older kidney transplant recipients: does age matter? J Am Soc Nephrol. 2004 Apr; 15(4):1052-60.
    View in: PubMed
    Score: 0.154
  32. Effects of the glutamate carboxypeptidase II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int. 2003 Jun; 63(6):2280-5.
    View in: PubMed
    Score: 0.146
  33. Physiological Age by Artificial Intelligence-Enhanced Electrocardiograms as a Novel Risk Factor of Mortality in Kidney Transplant Candidates. Transplantation. 2023 06 01; 107(6):1365-1372.
    View in: PubMed
    Score: 0.143
  34. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002 Sep-Oct; 22(5):417-30.
    View in: PubMed
    Score: 0.138
  35. Late nephrologist referral and access to renal transplantation. Transplantation. 2002 Jun 27; 73(12):1918-23.
    View in: PubMed
    Score: 0.137
  36. The impact of COVID-19 on kidney transplantation and the kidney transplant recipient - One year into the pandemic. Transpl Int. 2021 04; 34(4):612-621.
    View in: PubMed
    Score: 0.125
  37. KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation. Kidney Int. 2020 12; 98(6):1407-1418.
    View in: PubMed
    Score: 0.123
  38. A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes. PLoS One. 2019; 14(7):e0218709.
    View in: PubMed
    Score: 0.111
  39. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 06; 95(6):1304-1317.
    View in: PubMed
    Score: 0.110
  40. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481.
    View in: PubMed
    Score: 0.106
  41. Drug-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Kidney Transplant Recipients. Transplantation. 2017 Apr; 101(4):851-857.
    View in: PubMed
    Score: 0.095
  42. The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant Recipients. Clin Lab. 2016 Oct 01; 62(10):1965-1972.
    View in: PubMed
    Score: 0.092
  43. Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease. Trials. 2016 08 12; 17:401.
    View in: PubMed
    Score: 0.091
  44. A Cost Analysis of Tolerance Induction for Two-Haplotype Match Kidney Transplant Recipients. Am J Transplant. 2016 Jan; 16(1):371-3.
    View in: PubMed
    Score: 0.086
  45. State medicaid coverage, ESRD incidence, and access to care. J Am Soc Nephrol. 2014 Jun; 25(6):1321-9.
    View in: PubMed
    Score: 0.077
  46. Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2149-57.
    View in: PubMed
    Score: 0.075
  47. Multivessel coronary revascularization and outcomes in kidney transplant recipients. Transpl Int. 2013 Nov; 26(11):1080-7.
    View in: PubMed
    Score: 0.074
  48. Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipients. Transplantation. 2013 Jun 15; 95(11):1338-45.
    View in: PubMed
    Score: 0.073
  49. Quantifying the benefit of early living-donor renal transplantation with a simulation model of the Dutch renal replacement therapy population. Nephrol Dial Transplant. 2012 Jan; 27(1):429-34.
    View in: PubMed
    Score: 0.063
  50. Late referral to paediatric renal failure service impairs access to pre-emptive kidney transplantation in children. Arch Dis Child. 2010 Aug; 95(8):634-8.
    View in: PubMed
    Score: 0.059
  51. HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival. BMC Nephrol. 2010 Apr 01; 11:5.
    View in: PubMed
    Score: 0.058
  52. Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials. Transplantation. 2009 Dec 27; 88(12):1377-85.
    View in: PubMed
    Score: 0.057
  53. Educational level as a determinant of access to and outcomes after kidney transplantation in the United States. Am J Kidney Dis. 2008 May; 51(5):811-8.
    View in: PubMed
    Score: 0.051
  54. Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients. Transpl Int. 2007 Mar; 20(3):247-55.
    View in: PubMed
    Score: 0.047
  55. The association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use during postischemic acute transplant failure and renal allograft survival. Transplantation. 2006 Dec 15; 82(11):1441-8.
    View in: PubMed
    Score: 0.047
  56. Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation. Transpl Int. 2006 Aug; 19(8):629-35.
    View in: PubMed
    Score: 0.045
  57. Prognostic associations between lipid markers and outcomes in kidney transplant recipients. Am J Kidney Dis. 2006 Mar; 47(3):509-17.
    View in: PubMed
    Score: 0.044
  58. Endothelial progenitor cells in kidney transplant recipients. Transplantation. 2006 Feb 27; 81(4):599-606.
    View in: PubMed
    Score: 0.044
  59. Anaemia after renal transplantation. Eur J Clin Invest. 2005 Dec; 35 Suppl 3:89-94.
    View in: PubMed
    Score: 0.043
  60. Long-term patient and graft survival in the eurotransplant senior program: a single-center experience. Transplantation. 2005 Sep 15; 80(5):582-9.
    View in: PubMed
    Score: 0.043
  61. Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction. Clin Transplant. 2004 Aug; 18(4):341-8.
    View in: PubMed
    Score: 0.039
  62. Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease. Expert Opin Investig Drugs. 2000 Nov; 9(11):2637-51.
    View in: PubMed
    Score: 0.030
  63. Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population. J Am Soc Nephrol. 2019 02; 30(2):346-353.
    View in: PubMed
    Score: 0.027
  64. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc. 2018 07 06; 7(14).
    View in: PubMed
    Score: 0.026
  65. Perspectives on Pregnancy in Women With CKD: A Semistructured Interview Study. Am J Kidney Dis. 2015 Dec; 66(6):951-61.
    View in: PubMed
    Score: 0.021
  66. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial. PLoS One. 2015; 10(8):e0135674.
    View in: PubMed
    Score: 0.021
  67. Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Arthritis Care Res (Hoboken). 2011 Dec; 63(12):1642-53.
    View in: PubMed
    Score: 0.016
  68. End-stage renal disease due to lupus nephritis among children in the US, 1995-2006. Arthritis Rheum. 2011 Jul; 63(7):1988-97.
    View in: PubMed
    Score: 0.016
  69. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum. 2011 Jun; 63(6):1681-8.
    View in: PubMed
    Score: 0.016
  70. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol. 2006 Mar; 17(3):889-99.
    View in: PubMed
    Score: 0.011
  71. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002 Sep 23; 162(17):2002-6.
    View in: PubMed
    Score: 0.009
  72. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J Am Soc Nephrol. 2000 Jun; 11(6):1106-1116.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.